Deep Medicine Acquisition Valuation
| DMAQDelisted Stock | USD 11.59 0.12 1.02% |
At this time, the firm appears to be overvalued. Deep Medicine Acquisition shows a prevailing Real Value of $9.84 per share. The current price of the firm is $11.59. Our model computes the value of Deep Medicine Acquisition from reviewing the firm fundamentals such as Shares Outstanding of 4.36 M, shares owned by insiders of 74.08 %, and Shares Owned By Institutions of 28.73 % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Deep Medicine's price fluctuation is very steady at this time. Calculation of the real value of Deep Medicine Acquisition is based on 3 months time horizon. Increasing Deep Medicine's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Deep Medicine's intrinsic value may or may not be the same as its current market price of 11.59, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.59 | Real 9.84 | Hype 11.59 | Naive 11.58 |
The intrinsic value of Deep Medicine's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Deep Medicine's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Deep Medicine Acquisition helps investors to forecast how Deep stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Deep Medicine more accurately as focusing exclusively on Deep Medicine's fundamentals will not take into account other important factors: Deep Medicine Total Value Analysis
Deep Medicine Acquisition is currently forecasted to have valuation of 15.74 M with market capitalization of 12.9 M, debt of 1.86 M, and cash on hands of 707.98 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Deep Medicine fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.74 M | 12.9 M | 1.86 M | 707.98 K |
Deep Medicine Asset Utilization
One of the ways to look at asset utilization of Deep is to check how much profit was generated for every dollar of assets it reports. Deep Medicine Acquisition shows a negative utilization of assets of -0.0176 percent, losing $1.76E-4 for each dollar of assets held by the firm. Unsuccessful asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Deep Medicine Acquisition shows how unproductive it operates for each dollar spent on its assets.Deep Medicine Ownership Allocation
The market capitalization of Deep Medicine Acquisition is $12.9 Million. Deep Medicine Acquisition shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 74.08 percent of Deep Medicine Acquisition outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Also note that almost one hundred twenty-two thousand four hundred fifty-nine invesors are currently shorting Deep Medicine expressing very little confidence in its future performance.Deep Medicine Profitability Analysis
Net Loss for the year was (400.23 K) with profit before overhead, payroll, taxes, and interest of 0.About Deep Medicine Valuation
The delisted stock valuation mechanism determines Deep Medicine's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Deep Medicine Acquisition based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Deep Medicine. We calculate exposure to Deep Medicine's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Deep Medicine's related companies.Deep Medicine Acquisition Corp. does not have significant operations. The company was incorporated in 2020 and is based in New York, New York. Deep Medicine is traded on NASDAQ Exchange in the United States.
Deep Medicine Growth Indicators
Investing in growth stocks can be very risky. If the company such as Deep Medicine does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 2.3 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Deep Stock
If you are still planning to invest in Deep Medicine Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Deep Medicine's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |